Milton Werner | executive |
Joseph Frattaroli | executive |
Edward White | analyst |
Hello, and welcome to the Inhibikase Therapeutics Third Quarter 2023 Financial Results. [Operator Instructions] Please note today's event is being recorded. I'll now turn the conference over to Alexander Lobo of Stern Investor Relations. Please go ahead, sir.
Thank you, operator.